Industry profile

Electroplating. Typical wastes produced include spent process solutions containing copper, nickel, chromium, brass, bronze, zinc, tin, lead, cadmium, iron, aluminum, and compounds formed from these metals. 

Electroless plating. The most common wastes produced are spent process solutions containing copper and nickel. 

Etching and chemical milling. Typical solutions used in etching and milling that ultimately 

Cleaning. Various organic and inorganic compounds enter the wastewater stream from cleaning operations. 

Another pathway by which targeted pollutants enter the wastewater stream is through the disposal of spent batch process solutions into the sewer system. Spent solutions consist of aqueous wastes and may contain accumulated solids as well. Spent solutions are typically bled at a controlled rate into the wastewater stream. Other sources of pollutants in wastewater streams include cleanup of spills and washdown of fugitive aerosols from spray operations. 

---

Regulatory and legal aspects of drug development, 27. Industry Profile, Pharmaceutical Research and Manufacturers of America, Washington, DC, 2000, pp. 22-47. 

This issue also has been examined using a broad sample of products over the period 1984 to 1997. PhRMA, Pharmaceutical Industry Profile 2003, Available at www.pharma.org... 

Pharmaceutical Industry Profile, Pharmaceutical Research and Manufacturers of America... 

Figure 1.2 R D investments by research-based US pharmaceutical companies. Source. The Pharmaceutical Research and Manufacturers of America (PhRMA). Pharmaceutical Industry Profile 2006. http //www.phrma.org/files/2006%20Indusry%20 Profile.pdf, and http //www.phrma.org/news room/press releases/r%26d spending by u.s. biopharmaceutical companies reaches a record %2455.2 billion in 2006/ [accessed July 7, 2007].

Source The Pharmaceutical Research and Manufacturers of America (PhRMA). Pharmaceutical Industry Profile 2006. http //www.phrma.org/files/2006%20Indusry%20Profile.pdf [accessed July 27,2007]. 

Eahmi, T., 2005, Cultivation Experiences in Egypt. In Chamomile - Industrial Profiles (R. Eranke and H. Sehileher, eds.), CRC Press, Taylor Francis Group, Boca Raton, London, New York, Singapore, pp 156-162, ISBN 0-415-33463-2. 

Table 4 Industry Profile of Toxic and Classical Pollutant Loadings, Verification, and Screening Data (Toxic Pollutants Kg/kkg)... 

Kfen V, Cvak L (eds) (1999) Ergot - genus Claviceps, medicinal and aromatic plants -industrial profiles. Harwood Publ Ltd, Amsterdam, London, pp 1-515... 

Data audits of IMS Health as reported in PhRMA 2000 Pharmaceutical Industry Profile and subsequent IMS news releases. 

Peyron L (2002) Medicinal and Aromatic Plants—Industrial Profiles 26 148... 

Halpin, D. 2004a. A farm level view of the Australian organic industry. In Halpin, D. (ed.) Australian Organic Industry Profile. Department of Agriculture, Fisheries and Forestry, Canberra, pp. 1-29. 

Global Intellectual Property Protection, in Pharmaceutical Industry Profile 2001,... 

Heiden Associates (1987) Additional Industry Profile Data for Evaluating Compliance with Three Butadiene Workplace PEL Scenarios, Washington, DC... 

F. W. Lichtenthaler and P. Pokinskyj, Exploitation of sucrose towards products with industrial profiles, in W. Praznik and H. Huber (Eds.), Carbohydrates as Organic Raw Materials, Vol. 4, WUV-Univ, Vienna, 1998, pp. 9-19. 

National Association of Chain Drug Stores. 2006. 2006 Foundation Industry Profile. Alexandria, VA National Association of Chain Drug Stores. 

National Association of Chain Drug Stores (NACDS). 2006. The Chain Pharmacy Industry Profile 2006. Alexandria, VA National Association of Chain Drug Stores. Nelson B, Economy P. 2003. Managing for Dummies, 2d ed. New York Wiley. 

Industry Profile Study, 1973" National Agricultural Chemicals Association, Washington, D.C. 

Industrial Profile, U.S. Office of Industrial Technology, http //www.oit.doe.gov/chemicals/profile.shtml. 

---